Cocrystal Pharma Files 10Q Quarterly Report Highlighting Clinical Pipeline Progress Immuneering Reports Q1 2026 Financial Results Highlights Promising Pancreatic Cancer Data Ahead of ASCO 2026 Jim Cramer Praises Trane Technologies The Whole Business Is Thriving Arlo ARLO Crushes Q1 2026 Estimates EPS 028 Tops Views US CEOs Musk Cook and Nvidias Huang Join Trump on China Trade Mission Marc Jacobs Departs LVMH After Three Decades Remains Creative Director as Brand Changes Hands VS Q4 2025 Earnings Net Loss Per Share of 020 Amid Zero Revenue Stock Rises 283 Sammaan Capital Reports 8101 Crore Loss as Impairments Surge in March Quarter IKEA and Japanese Rivals Compete for Space in Shrinking Japanese Homes Microsoft Appoints New Trusted Technology Head to Balance AI Speed with Responsible Development Microsoft Flags 190B Capital Spending Need by 2026 Amid Memory Price Surge Healthcare and Tech Lead SP 500 to Modest Gains Trumps AIGenerated Images Spotlight Renewed Greenland Focus Raising Geopolitical Questions Memory Chip Crunch Poses New Challenges for Chinese Automakers From BYD to Xpeng FTAIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter WPC Q1 2026 Earnings EPS Surges 1822 Above Estimates Defying Market Expectations WFRD Q1 2026 Earnings Strong EPS Beat but Stock Declines CTRI Q1 2026 Earnings EPS Surprises Positively Despite Loss Stock Declines PENN Q1 2026 Earnings Steep EPS Miss Amid Operational Headwinds STRW Q1 2026 Earnings EPS Beats Estimates by Nearly 15 ITHAX Acquisition Corp III ITHAU Units Hold Steady at 1004 Amid Consolidation Duluth Holdings DLTH Rises Moderately as Volume Highlights Tentative Buying Interest RERE Holds Steady Near Support ATRenew Inc ADR Trading in Narrow Range RELX RELX Edges Lower Near 3285 as Shares Consolidate Between Key Levels Yorkville Acquisition Corp Warrant MCGAW Slips 171 as Trading Volume Remains Modest UK Grocery Price Inflation Why Everyday Essentials Like Eggs Have Surged Since 2022 NWPX Q1 2026 Earnings Earnings Surge Past Estimates with 5571 Surprise Definium Therapeutics DFTX Surges 341 as Volume Picks Up Testing Key Resistance